Literature DB >> 25336603

Personalized approach to revascularization of critical limb ischemia.

Mehdi H Shishehbor1, Grant W Reed2.   

Abstract

Entities:  

Keywords:  Editorials; peripheral arterial disease; wound healing

Mesh：

Year:  2014        PMID： 25336603     DOI： 10.1161/CIRCINTERVENTIONS.114.001923

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  5 in total

1.  Microvascular Disease, Peripheral Artery Disease, and Amputation.

Authors:  Joshua A Beckman; Meredith S Duncan; Scott M Damrauer; Quinn S Wells; Joey V Barnett; David H Wasserman; Roger J Bedimo; Adeel A Butt; Vincent C Marconi; Jason J Sico; Hilary A Tindle; Marc P Bonaca; Aaron W Aday; Matthew S Freiberg
Journal:  Circulation       Date:  2019-07-08       Impact factor: 29.690

Review 2.  Role of Nitric Oxide Carried by Hemoglobin in Cardiovascular Physiology: Developments on a Three-Gas Respiratory Cycle.

Authors:  Richard T Premont; James D Reynolds; Rongli Zhang; Jonathan S Stamler
Journal:  Circ Res       Date:  2019-10-08       Impact factor: 17.367

3.  Effects of Lower Limb Revascularization on the Microcirculation of the Foot: A Retrospective Cohort Study.

Authors:  Gennady Geskin; Michael D Mulock; Nicole L Tomko; Anna Dasta; Sandeep Gopalakrishnan
Journal:  Diagnostics (Basel)       Date:  2022-05-26

4.  SPECT/CT Imaging: A Noninvasive Approach for Evaluating Serial Changes in Angiosome Foot Perfusion in Critical Limb Ischemia.

Authors:  Ting-Heng Chou; Said A Atway; Adam J Bobbey; Timur P Sarac; Michael R Go; Mitchel R Stacy
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-24       Impact factor: 4.730

5.  Hospital Readmissions Following Endovascular Therapy for Critical Limb Ischemia: Associations With Wound Healing, Major Adverse Limb Events, and Mortality.

Authors:  Grant W Reed; Pejman Raeisi-Giglou; Rami Kafa; Umair Malik; Negar Salehi; Mehdi H Shishehbor
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.